Sirona Biochem Announces CFDA Approval of SGLT2 Inhibitor for Phase I Clinical Trial Biotech Investing
Zogenix Announces Positive Top-line Results from Second Pivotal Phase 3 Clinical Trial of ZX008 in Dravet Syndrome Pharmaceutical Investing
Asterias Biotherapeutics Announces New Exclusive License Agreement with The Regents of the University of California Biotech Investing
Phase 3 Trial of NINLARO (ixazomib) as Maintenance Therapy Met Primary Endpoint Pharmaceutical Investing
ResMed, Verily to Form Joint Venture to Help Reach Millions of Untreated Sleep Apnea Sufferers Medical Device Investing
Bioasis and BioAgilytix Announce Strategic Collaboration to Advance xB3 TM-001, Bioasis’ Lead Investigational Candidate to Treat HER2+ Brain Cancer, to IND Submission and into the Clinic Biotech Investing
Bristol-Myers Squibb’s Opdivo (nivolumab) + Low-Dose Yervoy (ipilimumab) is the First Immuno-Oncology Combination Approved for MSI-H/dMMR mCRC Patients Biotech Investing
FDA Grants Priority Review to Merck’s Supplemental Biologics License Application for KEYTRUDA (pembrolizumab) for the Treatment of Patients with Advanced Hepatocellular Carcinoma Pharmaceutical Investing
Medtronic Receives FDA Approval for Less-Invasive Heart Pump Implant Procedure Medical Device Investing
